top of page


HCV liver

HIV Virus

HCV liver
1/2
Claudia T. Martorell, MD MPH FACP
Board Certified Infectious Diseases
57 Mulberry Street Springfield MA 01105
phone 413-747-5566 fax 413-747-5666
Research/Clinical Trials at current location
01
02
03
04
05
06
07
08
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching From a Regimen of Dolutegravir and Either
Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Combination of Bictegravir/ Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Subjects Who Are Virologically Suppressed
09
NP-303-103- A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living with HIV/AIDS (PLWHA) with Non-Infectious Diarrhea
bottom of page